9,10-dimethyl-1,2-benzanthracene has been researched along with nutlin-3a in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Box, NF; Boyle, GM; Dai, D; Gonzalez, V; Lozano, G; Murao, K; Pollock, PM; Powell, MB; Robinson, SE; Robinson, WA; Roop, DR; Stiegmann, RA; Terzian, T; Torchia, EC | 1 |
1 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and nutlin-3a
Article | Year |
---|---|
p53 prevents progression of nevi to melanoma predominantly through cell cycle regulation.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cellular Senescence; Clone Cells; Disease Models, Animal; Disease Progression; Humans; Imidazoles; Melanocytes; Melanoma; Mice; Mice, Inbred C57BL; Nevus; Pigmentation; Piperazines; Proto-Oncogene Proteins; Skin Neoplasms; Staining and Labeling; Survival Analysis; Transcription, Genetic; Tumor Suppressor Protein p53; Ubiquitin-Protein Ligases | 2010 |